RecruitingNCT05919758

Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix

The Value of Complementary Right-sided Hemicolectomy for Pediatric Patients With High-risk Neuroendocrine Tumors (NETs) of the Appendix; Towards the Development of an (Inter-) National Consensus Guideline for the Pediatric Population.

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment

1,000 participants

Start Date

May 1, 2023

Study Type

OBSERVATIONAL

Conditions

Neoplasms Appendix Cancer

Summary

The goal of this observational study is to investigate the beneficial value of complementary surgery for appendiceal neuro-endocrine tumours in children. .

Eligibility

Max Age: 17 Years

Inclusion Criteria2

All patients that were treated for an appendiceal NET before the age of 18 years old
Time period: 1990-2020

Exclusion Criteria4

Other appendiceal malignancies/tumours, for example:
goblet cell carcinoma
adenocarcinoma
neuroendocrine carcinoma

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Amsterdam UMC

Amsterdam-Zuidoost, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05919758

Related Trials

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

NCT068856971 location

Collection of Tissue Specimens From Patients With Solid Tumors or Blood Disorders and Their HLA-Compatible Family Members

NCT000710451 location